All companies

Investors & Advisers

Apax

Ecosystem Private
Headquarters
London, GB
Segment
Investors & Advisers
Stories held
2
Last story
1 Oct 2026

Apax Partners LLP is a London-based private equity firm investing globally across technology, internet/consumer, healthcare and services sectors, including packaging-related holdings such as Gerresheimer's Moulded Glass business. The firm has raised and advised funds totalling roughly USD 77bn.

2 stories · 2026

Gerresheimer completes Centor sale to Apax funds, half of EUR 1.5bn disposal package

Gerresheimer completed the sale of its US closures subsidiary Centor to funds advised by Apax Partners on 1 October 2026, about two months after signing on 29 July 2026. Centor accounts for roughly half of the combined enterprise value of about EUR 1.5bn (USD 1.7bn) agreed for Centor and the group's global Primary Packaging Plastics business. The proceeds go to debt reduction; the Primary Packaging Plastics sale is still expected to close in the first half of 2027, followed by a group refinancing.

Why this mattersThe closures exit funds deleveraging and leaves Gerresheimer concentrated on primary pharmaceutical packaging and drug-delivery systems, with one disposal still to run.

  • Centor sale completed on 1 October 2026, about two months after the agreement signed on 29 July 2026
  • Buyer is funds advised by Apax Partners
  • Centor represents about half of the combined enterprise value of roughly EUR 1.5bn (USD 1.7bn) agreed for Centor and Primary Packaging Plastics
  • Proceeds are earmarked for debt reduction, according to CFO Wolf Lehmann
  • Primary Packaging Plastics disposal is expected to close in the first half of 2027, with a comprehensive group refinancing prepared with lenders afterwards
  • Gerresheimer reports Q3 2026 results on 31 October 2026
Gerresheimer Apax Partners counterparty Apax counterparty Centor
Relevant to you?

Gerresheimer's Moulded Glass EBITDA falls 81% in Q1 2026

Gerresheimer's Q1 2026 results show adjusted EBITDA in its Moulded Glass segment dropping to EUR 6m from EUR 32m a year earlier, as revenue fell to EUR 144m from EUR 160m, while the Containment and Delivery Systems unit grew adjusted EBITDA to EUR 61m from EUR 51m. Free cash flow before M&A improved to negative EUR 32m from negative EUR 142m as net capex was cut to EUR 56m from EUR 113m, with the group counting on its planned EUR 1.5bn disposal of Centor and Primary Packaging Plastics to Apax Funds to support deleveraging.

Why this mattersA sharp glass-segment profit collapse alongside a large planned plastics disposal underlines Gerresheimer's pivot toward medical delivery systems while it manages deleveraging pressure.

  • Moulded Glass adjusted EBITDA fell to EUR 6m in Q1 2026 from EUR 32m a year earlier, an 81% decline.
  • Moulded Glass revenue dropped to EUR 144m from EUR 160m in the quarter.
  • Containment and Delivery Systems revenue rose 8.8% organically to EUR 296m, with adjusted EBITDA up to EUR 61m from EUR 51m.
  • Free cash flow before M&A improved to negative EUR 32m from negative EUR 142m in Q1 2025.
  • Net capital expenditure fell to EUR 56m from EUR 113m in the quarter.
  • Gerresheimer expects the planned EUR 1.5bn sale of Centor and Primary Packaging Plastics to support deleveraging.
Gerresheimer Apax counterparty
Relevant to you?